Concentrations
Displaying growth conditions 701 - 725 of 1187 in total
| ECMDB ID | Name | Concentration | Strain Media | Growth Status Growth System | Temperature | Citation |
|---|---|---|---|---|---|---|
| ECMDB22058 | CL(16:0/16:0/19:0cycv8c/14:0) | 0.06756± 0.0 uM | K12 Luria-Bertani (LB) media | Stationary phase cultures (overnight culture) Shake flask | 37 oC | PMID: 22956318 |
| ECMDB22215 | CL(16:0/17:0cycw7c/17:0cycw7c/18:1(9Z)) | 0.05457± 0.0 uM | K12 Luria-Bertani (LB) media | Stationary phase cultures (overnight culture) Shake flask | 37 oC | PMID: 22956318 |
| ECMDB00295 | Uridine 5'-diphosphate | 1790± 0 uM | K12 NCM3722 Gutnick minimal complete medium (4.7 g/L KH2PO4; 13.5 g/L K2HPO4; 1 g/L K2SO4; 0.1 g/L MgSO4-7H2O; 10 mM NH4Cl) with 4 g/L glucose | Mid-Log Phase Shake flask and filter culture | 37 oC | PMID: 19561621 |
| ECMDB21402 | Isobutyryl-CoA | 8± 0 uM | BW25113 48 mM Na2HPO4, 22 mM KH2PO4, 10 mM NaCl, 45 mM (NH4)2SO4, supplemented with 1 mM MgSO4, 1 mg/l thiamine·HCl, 5.6 mg/l CaCl2, 8 mg/l FeCl3, 1 mg/l MnCl2·4H2O, 1.7 mg/l ZnCl2, 0.43 mg/l CuCl2·2H2O, 0.6 mg/l CoCl2·2H2O and 0.6 mg/l Na2MoO4·2H2O. 4 g/L Gluco | Stationary Phase, glucose limited Bioreactor, pH controlled, O2 and CO2 controlled, dilution rate: 0.2/h | 37 oC | PMID: 17379776 |
| ECMDB00158 | L-Tyrosine | 77± 6 uM | BL21 DE3 Luria-Bertani (LB) media | Stationary phase cultures (overnight culture) Shake flask | 37 oC | Experimentally Determined Download Details |
| ECMDB22059 | CL(16:0/16:0/17:0cycw7c/16:0) | 0.06756± 0.0 uM | K12 Luria-Bertani (LB) media | Stationary phase cultures (overnight culture) Shake flask | 37 oC | PMID: 22956318 |
| ECMDB22415 | CL(16:1(9Z)/19:0cycv8c/19:0cycv8c/14:0) | 0.05457± 0.0 uM | K12 Luria-Bertani (LB) media | Stationary phase cultures (overnight culture) Shake flask | 37 oC | PMID: 22956318 |
| ECMDB00295 | Uridine 5'-diphosphate | 386± 0 uM | BW25113 48 mM Na2HPO4, 22 mM KH2PO4, 10 mM NaCl, 45 mM (NH4)2SO4, supplemented with 1 mM MgSO4, 1 mg/l thiamine·HCl, 5.6 mg/l CaCl2, 8 mg/l FeCl3, 1 mg/l MnCl2·4H2O, 1.7 mg/l ZnCl2, 0.43 mg/l CuCl2·2H2O, 0.6 mg/l CoCl2·2H2O and 0.6 mg/l Na2MoO4·2H2O. 4 g/L Gluco | Stationary Phase, glucose limited Bioreactor, pH controlled, O2 and CO2 controlled, dilution rate: 0.2/h | 37 oC | PMID: 17379776 |
| ECMDB21403 | 2-Aminoisobutyric acid | 11± 0 uM | BW25113 48 mM Na2HPO4, 22 mM KH2PO4, 10 mM NaCl, 45 mM (NH4)2SO4, supplemented with 1 mM MgSO4, 1 mg/l thiamine·HCl, 5.6 mg/l CaCl2, 8 mg/l FeCl3, 1 mg/l MnCl2·4H2O, 1.7 mg/l ZnCl2, 0.43 mg/l CuCl2·2H2O, 0.6 mg/l CoCl2·2H2O and 0.6 mg/l Na2MoO4·2H2O. 4 g/L Gluco | Stationary Phase, glucose limited Bioreactor, pH controlled, O2 and CO2 controlled, dilution rate: 0.2/h | 37 oC | PMID: 17379776 |
| ECMDB00883 | L-Valine | 1623± 108 uM | BL21 DE3 Luria-Bertani (LB) media | Stationary phase cultures (overnight culture) Shake flask | 37 oC | Experimentally Determined Download Details |
| ECMDB22068 | CL(16:0/16:0/14:0/19:0cycv8c) | 0.06756± 0.0 uM | K12 Luria-Bertani (LB) media | Stationary phase cultures (overnight culture) Shake flask | 37 oC | PMID: 22956318 |
| ECMDB22423 | CL(16:1(9Z)/19:0cycv8c/14:0/19:0cycv8c) | 0.05457± 0.0 uM | K12 Luria-Bertani (LB) media | Stationary phase cultures (overnight culture) Shake flask | 37 oC | PMID: 22956318 |
| ECMDB00296 | Uridine | 2090± 0 uM | K12 NCM3722 Gutnick minimal complete medium (4.7 g/L KH2PO4; 13.5 g/L K2HPO4; 1 g/L K2SO4; 0.1 g/L MgSO4-7H2O; 10 mM NH4Cl) with 4 g/L glucose | Mid-Log Phase Shake flask and filter culture | 37 oC | PMID: 19561621 |
| ECMDB21404 | 2,4-Diaminobutyric acid | 33± 0 uM | BW25113 48 mM Na2HPO4, 22 mM KH2PO4, 10 mM NaCl, 45 mM (NH4)2SO4, supplemented with 1 mM MgSO4, 1 mg/l thiamine·HCl, 5.6 mg/l CaCl2, 8 mg/l FeCl3, 1 mg/l MnCl2·4H2O, 1.7 mg/l ZnCl2, 0.43 mg/l CuCl2·2H2O, 0.6 mg/l CoCl2·2H2O and 0.6 mg/l Na2MoO4·2H2O. 4 g/L Gluco | Stationary Phase, glucose limited Bioreactor, pH controlled, O2 and CO2 controlled, dilution rate: 0.2/h | 37 oC | PMID: 17379776 |
| ECMDB03357 | N-Acetylornithine | 0.61± 0.03 uM | BL21 DE3 Luria-Bertani (LB) media | Stationary phase cultures (overnight culture) Shake flask | 37 oC | Experimentally Determined Download Details |
| ECMDB22159 | CL(16:0/19:0cycv8c/16:0/14:0) | 0.06756± 0.0 uM | K12 Luria-Bertani (LB) media | Stationary phase cultures (overnight culture) Shake flask | 37 oC | PMID: 22956318 |
| ECMDB22473 | CL(16:1(9Z)/14:0/19:0cycv8c/19:0cycv8c) | 0.05457± 0.0 uM | K12 Luria-Bertani (LB) media | Stationary phase cultures (overnight culture) Shake flask | 37 oC | PMID: 22956318 |
| ECMDB00397 | 2-Pyrocatechuic acid | 138± 0 uM | K12 NCM3722 Gutnick minimal complete medium (4.7 g/L KH2PO4; 13.5 g/L K2HPO4; 1 g/L K2SO4; 0.1 g/L MgSO4-7H2O; 10 mM NH4Cl) with 4 g/L glucose | Mid-Log Phase Shake flask and filter culture | 37 oC | PMID: 19561621 |
| ECMDB21405 | Diethanolamine | 20± 0 uM | BW25113 48 mM Na2HPO4, 22 mM KH2PO4, 10 mM NaCl, 45 mM (NH4)2SO4, supplemented with 1 mM MgSO4, 1 mg/l thiamine·HCl, 5.6 mg/l CaCl2, 8 mg/l FeCl3, 1 mg/l MnCl2·4H2O, 1.7 mg/l ZnCl2, 0.43 mg/l CuCl2·2H2O, 0.6 mg/l CoCl2·2H2O and 0.6 mg/l Na2MoO4·2H2O. 4 g/L Gluco | Stationary Phase, glucose limited Bioreactor, pH controlled, O2 and CO2 controlled, dilution rate: 0.2/h | 37 oC | PMID: 17379776 |
| ECMDB00177 | L-Histidine | 0.22± 0.01 uM | BL21 DE3 Luria-Bertani (LB) media | Stationary phase cultures (overnight culture) Shake flask | 37 oC | Experimentally Determined Download Details |
| ECMDB22182 | CL(16:0/19:0cycv8c/14:0/16:0) | 0.06756± 0.0 uM | K12 Luria-Bertani (LB) media | Stationary phase cultures (overnight culture) Shake flask | 37 oC | PMID: 22956318 |
| ECMDB22534 | CL(18:1(9Z)/16:0/17:0cycw7c/17:0cycw7c) | 0.05457± 0.0 uM | K12 Luria-Bertani (LB) media | Stationary phase cultures (overnight culture) Shake flask | 37 oC | PMID: 22956318 |
| ECMDB00397 | 2-Pyrocatechuic acid | 414± 0 uM | K12 NCM3722 Gutnick minimal complete medium (4.7 g/L KH2PO4; 13.5 g/L K2HPO4; 1 g/L K2SO4; 0.1 g/L MgSO4-7H2O; 10 mM NH4Cl) with 4 g/L glycerol | Mid-Log Phase Shake flask and filter culture | 37 oC | PMID: 19561621 |
| ECMDB21406 | 2-Mercapto-1-methylimidazole | 186± 0 uM | BW25113 48 mM Na2HPO4, 22 mM KH2PO4, 10 mM NaCl, 45 mM (NH4)2SO4, supplemented with 1 mM MgSO4, 1 mg/l thiamine·HCl, 5.6 mg/l CaCl2, 8 mg/l FeCl3, 1 mg/l MnCl2·4H2O, 1.7 mg/l ZnCl2, 0.43 mg/l CuCl2·2H2O, 0.6 mg/l CoCl2·2H2O and 0.6 mg/l Na2MoO4·2H2O. 4 g/L Gluco | Stationary Phase, glucose limited Bioreactor, pH controlled, O2 and CO2 controlled, dilution rate: 0.2/h | 37 oC | PMID: 17379776 |
| ECMDB02005 | Methionine sulfoxide | 7± 1 uM | BL21 DE3 Luria-Bertani (LB) media | Stationary phase cultures (overnight culture) Shake flask | 37 oC | Experimentally Determined Download Details |